Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.
about
Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.Metabolic advantages and vulnerabilities in brain metastases.Synergistic anti-tumor effects of dasatinib and dendritic cell vaccine on metastatic breast cancer in a mouse model.Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
P2860
Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.
@ast
Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.
@en
type
label
Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.
@ast
Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.
@en
prefLabel
Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.
@ast
Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.
@en
P2093
P2860
P50
P356
P1433
P1476
Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.
@en
P2093
Claire Bristow
Kleopatra Andreou
Nicola R Sibson
Timothy D W Claridge
P2860
P304
P356
10.7150/THNO.16538
P577
2016-09-12T00:00:00Z